Displaying considerable expertise in managing complex SPAC transactions and multi-jurisdictional M&A, the Dechert LLP is frequently instructed by Chinese corporations and global entities. The firm is especially active in the life sciences, tech, and financial services fields, regularly supporting clients on corporate restructurings. Spearheading the outfit, Yang Wang is located in both Beijing and Hong Kong, primarily specialising in PRC outbound investments.

Legal 500 Editorial commentary

Key clients

  • Baird Medical Investment Holdings Limited
  • Nocturne Acquisition Corporation
  • Graham Partners
  • Kohlberg Kravis Roberts & Co.
  • MiddleGround Management, L.P.
  • Forebright Capital
  • Best Years, LLC
  • Agile Group

Work highlights

  • Advised Baird Medical Investment Holdings Limited, a leading medical device developer and provider, on its business combination with ExcelFin Acquisition Corporation (NASDAQ: XFIN), a publicly traded Special Purpose Acquisition Company (SPAC).
  • Advised Graham Partners, Inc. and certain of its affiliates in its acquisition of Taoglas Group Holdings Limited and certain of its subsidiaries, a global designer and manufacturer of advanced RF components.
  • Advised Nocturne Acquisition Corporation, a special purpose acquisition company in connection with its entry into a merger agreement with Cognos Therapeutics, Inc., a medical technology company focused on developing devices to deliver drugs for the treatment of neurological diseases.

Practice head

The lawyer(s) leading their teams.

Yang Wang